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Health and 3) Department of Bacteriology and Immunology, University of Helsinki, Helsinki, FinlandAbstractThe incidence of human infections caused by Campylobacter jejuni and Campylobacter coli, the main bacterial agents of gastrointestinal disease,
has been increasing worldwide. Here, we review the role of poultry as a source and reservoir for Campylobacter. Contamination and
subsequent colonization of broiler ﬂocks at the farm level often lead to transmission of Campylobacter along the poultry production chain
and contamination of poultry meat at retail. Yet Campylobacter prevalence in poultry, as well as the contamination level of poultry
products, vary greatly between different countries so there are differences in the intervention strategies that need to be applied.
Temporal patterns in poultry do not always coincide with those found in human infections. Studies in rural and urban areas have
revealed differences in Campylobacter infections attributed to poultry, as poultry seems to be the predominant reservoir in urban, but not
necessarily in rural, settings. Furthermore, foreign travel is considered a major risk factor in acquiring the disease, especially for
individuals living in the northern European countries. Intervention strategies aimed at reducing Campylobacter colonization in poultry and
focused at the farm level have been successful in reducing the number of Campylobacter cases in several countries. Increasing farm
biosecurity and education of consumers are likely to limit the risk of infection. Overall, poultry is an important reservoir and source of
human campylobacteriosis, although the contribution of other sources, reservoirs and transmission warrants more research.
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E-mail: hilpi.rautelin@medsci.uu.seCampylobacter infectionsOf the 25 Campylobacter species validly described to date
(http://www.bacterio.net/campylobacter.html, last accessed 21
August 2015), Campylobacter jejuni and Campylobacter coli are
the two predominant species causing gastrointestinal infections.
However, other species such as Campylobacter lari, Campylo-
bacter upsaliensis and Campylobacter concisus have also been
associated with gastrointestinal disease in humans. In this re-
view, C. jejuni and C. coli will be referred to as Campylobacter,
unless otherwise stated.Clinical Microbiology and Infection © 2015 The Authors. Published by El
This is an open access artiHuman campylobacteriosis typically develops 1–5 days after
exposure and is characterized by watery and sometimes bloody
diarrhoea, fever, abdominal cramps and vomiting lasting for
approximately 5–7 days. Campylobacteriosis is the most
common infection preceding the onset of post-infectious
Guillain–Barré syndrome, a severe demyelinating neuropathy,
occurring in approximately 3/10 000 campylobacteriosis cases
[1]. Furthermore, other sequelae, such as reactive arthritis and
irritable bowel syndrome, signiﬁcantly add to the burden of
disease [2]. Campylobacteriosis is usually self-limiting and anti-
microbial treatment is often not required, except in severe
cases or patients with a compromised immune status.
Several studies have estimated the burden of campylo-
bacteriosis, expressed as disability-adjusted life-years (DALYs).
Recent estimates range from 1 568 DALYs in New Zealand [3],
3 633 in The Netherlands [2] up to 18 222 in Australia [4] and
22 500 in the USA [1]. The major driver of DALYs forClin Microbiol Infect 2016; 22: 103–109
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TABLE 1. Campylobacteriosis worldwide
Continent / country Notiﬁcation rate/100 000 Year Reference
Europe
Austria 67.7 2013 [6]
Denmark 67.3 2013 [6]
Estonia 28.9 2013 [6]
Finland 74.9 2013 [6]
Germany 77.3 2013 [6]
Iceland 31.4 2013 [6]
Lithuania 38.3 2013 [6]
Norway 65.2 2013 [6]
Slovenia 49.9 2013 [6]
Sweden 84.9 2013 [6]
United Kingdom 104 2013 [6]
North America
Canada 29.3 2012 a
USA 13.5 2014 b
Oceania
Australia 112.3 2010 c
New Zealand 152.9 2013 d
aPublic Health Agency of Canada (http://dsol-smed.phac-aspc.gc.ca/dsol-smed/ndis/
charts.php?c=pl, last accessed 22 July 2015).
bCampylobacteriosis rate in 2014 in the USA, http://www.cdc.gov/foodnet/index.
html, last accessed 22 July 2015.
chttp://www.health.gov.au/internet/main/publishing.nsf/content/cda-cdi3601-pdf-
cnt.htm/$FILE/cdi3601a.pdf, last accessed 22 July 2015.
dhttp://www.foodsafety.govt.nz/elibrary/industry/FBI-report-2013.pdf, last accessed
28 July 2015.
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disability caused by sequelae of the infections [1,4]. Campylo-
bacter are a leading cause of bacterial enteritis in Europe [5] and
campylobacteriosis is also one of the most expensive food-
borne diseases in Europe and Oceania [2,3].
Table 1 gives an overview of the number of reported
Campylobacter cases worldwide. Many countries have a
mandatory Campylobacter notiﬁcation system and increasing
notiﬁcation rates of the disease have been shown [6]. For
example, in the European Union (EU) in 2009, 201 711
Campylobacter cases were reported, and this number increased
to 214 779 in 2013 [6]. In the USA, an increase of 13% was
shown in cases reported in 2014, compared with the ﬁgures
from the period 2006–2008 (http://www.cdc.gov/foodnet/
index.html, last accessed 28 July 2015).
Generally, Campylobacter infections peak in certain age
groups; young children (<4 years of age), young adults
(20–40 years of age) and the elderly (>75 years of age) [7,8],
which may be due to different risk factors in certain age groups
[7,9,10]. Reports from regions other than Europe and North
America are still scarce, and often show an overall low detec-
tion rate from human samples.Chicken food chain and CampylobacterPoultry encompasses chicken, turkey, duck and laying hens, of
which chicken (Gallus gallus) is the predominant species used
for meat production (70%–80%). Global poultry meat pro-
duction has increased from 58.5 million tonnes in 2000 to 95.5Clinical Microbiology and Infection © 2015 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licemillion tonnes in 2014 (http://www.thepoultrysite.com/focus/
global-poultry-trends/2400/global-poultry-trends-region-select-
track-poultry-trends-across-the-world, last accessed 25 August
2015). Production is not equally distributed; the Americas
accounted for 43% of the total production, Asia (mainly China)
for 34%, Europe for 17% and Africa and Oceania for 5% and 1%
of the whole production in 2012 (93 million tonnes), respec-
tively. In 2023, poultry meat is expected to be the largest meat
sector by around 130.7 million tonnes (OECD (2015), Meat
consumption, http://www.oecd-ilibrary.org/agriculture-and-
food/oecd-fao-agricultural-outlook_19991142, last accessed
31 August 2015). Although free-range and organic poultry
productions are also increasing in industrialized countries, their
quantities are still minor and beyond the scope of this review.
An Expert Opinion Assessment by the European Food Safety
Authority has estimated that chicken meat consumption ac-
counts for 20%–30% of campylobacteriosis in the EU, whereas
50%–80% may be attributed to the chicken reservoir as a
whole, stressing that broiler meat production accounts for
variable numbers of campylobacteriosis cases in different
countries [11]. This also means that the approximate doubling
of the chicken meat production from 58.5 million tonnes in
2000 to 95.5 million tonnes in 2014 has clearly affected the
global burden of campylobacteriosis and the continuing growth
of poultry meat production will put further pressure on the
poultry industry and public health authorities to reduce poultry/
chicken-associated human Campylobacter infections.
The stages in the chicken meat production and processing
chain consist of primary production at rearing farms, transport
to slaughter, the slaughter process and subsequent processing
of chicken meat products, selling products at the retail level,
and handling and consumption of chicken meat products at
home and in public places such as restaurants. All of these
stages have a role in the transmission of Campylobacter from
farm to fork. Production chain conditions vary between coun-
tries, and this is also reﬂected in the annual number of
Campylobacter-positive chicken ﬂocks. In the EU, the variation
in Campylobacter prevalence has been from 0.6% to 13.1% in the
Nordic countries Finland, Norway and Sweden, up to
74.2%–80% in several other countries [6]. Moreover,
Campylobacter prevalence on farms subsequently reﬂects the
presence of Campylobacter found on carcasses and meat
(Table 2).
The most important factors for slaughter batches to become
Campylobacter positive have been shown to be partial depop-
ulation of the ﬂock (thinning), slaughter in the summer (June,
July and August), increasing bird age at slaughter (from 36 days
to >40 days), common health status of the ﬂock (measured as
mortality) and increasing number of rearing houses at the farm
[12,13]. This indicates that the major contamination site in theEuropean Society of Clinical Microbiology and Infectious Diseases, CMI, 22, 103–109
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tical transmission from parent to young chicks is uncommon
and a ﬂock is usually identiﬁed as Campylobacter positive at the
age of approximately 2 weeks. Flocks at commercial production
systems consist of approximately 10 000–30 000 birds per
house, with several houses present at a farm, potentially facil-
itating high levels of Campylobacter ampliﬁcation and rapid
spread within the ﬂock. A ﬂock is either colonized by one strain
only or, at farms with less stringent biosecurity, multiple strains
can colonize the same ﬂock simultaneously [14]. Transport has
only a limited effect on the contamination of carcasses, whereas
during the slaughter process, plucking and evisceration lead to
contamination of carcasses. At the end of the processing line,
various types of products are on sale in different countries,
starting from fresh or frozen whole carcasses to pieces of cuts
and portions; this accounts for the divergent quantities of
infection risk. Generally, skinless portions such as breast ﬁllets
and slices contain lower Campylobacter counts than portions
with skin [11].EpidemiologyThe great majority of Campylobacter infections are sporadic,
and a wide variety of animal species can carry the organisms
in high numbers and act as a reservoir, which complicates
tracing and attribution of the original source of infection.
Human exposure can come through direct contact with ani-
mals, food (e.g. raw or undercooked meat and unpasteurized
milk) or environmental reservoirs (e.g. natural bodies of
water) [15]. Pulsed-ﬁeld gel electrophoresis, multilocus
sequence typing (MLST) and ﬂa-typing have all been methods
commonly used to study the distribution of different geno-
types in various reservoirs and sources [16–18]. As a resultTABLE 2. Prevalence of Campylobacter in European poultry meat a
Country Study period Type of sample
Austria 2013 Broiler meat
Denmark 2013 Broiler meat
Finland 2013 Broiler meat
France 2009 Broiler meat
Germany 2013 Broiler meat
The Netherlands 2013 Broiler meat
Hungary 2013 Broiler meat
Poland 2009–2013 Chicken meat
Turkey meat
Slovakia 2013 Broiler meat
Slovenia 2013 Broiler meat
Spain 2013 Broiler meat
Turkey 2009–2010 Chicken meat
aCc, Campylobacter coli; Cj, Campylobacter jejuni; ND, not discriminated.
Clinical Microbiology and Infection © 2015 The Authors. Published by Elsevier Ltd on behalf
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C. jejuni, MLST based on sequencing of seven housekeeping
genes has been particularly suitable to study the long-term
changes in sequence type (ST) distribution at both local and
global levels [18–20]. Subsequently, mathematical models
using MLST data have been employed to assign patient isolates
to potential sources. In studies employing MLST and mathe-
matical modelling, it has been found that chicken are the most
common reservoir/source of Campylobacter infection, with
attributions varying from 38% to 77%, whereas cattle have
been named as the second most common source, with
attribution rates varying between 16% and 54% (Table 3).
Generally, source attribution studies have greatly improved
our understanding of the relative contributions by different
sources to human infection. However, the assignment of one
source to one genotype by the source attribution model may
subsequently result in over-attribution of particular sources
to human infections. This has been particularly seen for
generalist genotypes, such as ST21 and ST45, which are
commonly found from a large number of sources and reser-
voirs, but often bovines or chickens are assigned as their
sources [7,21,22]. This issue can partially be resolved by
studying the allelic variation at genome level in a whole
genome MLST approach, which allows for a more reﬁned way
to resolve the association of possibly epidemiologically linked
isolates [23–25]. In addition, when MLST data are only
available for a limited number of potential sources apart from
poultry, this can lead to over-estimation of the role of
poultry. Ultimately, epidemiological studies using case–con-
trol data combined with robust typing of the isolates improve
sensitivity of the source attribution [22].
Seasonal peaks in human Campylobacter cases, mostly in
July–August, are commonly observed in western countries
with temperate climates [6,26–28], whereas this is less markedt retail
Prevalence Speciesa Reference
71% ND [6]
12% ND [6]
11% ND [6]
76% Cj: 65%
Cc: 35%
[48]
38% ND [6]
32% ND [6]
24% ND [6]
50%
41%
Cj: 40%
Cc: 37%
Cj: 31%
Cc: 69%
[49]
36% ND [6]
54% ND [6]
70% ND [6]
56% Cj: 42%
Cc: 14%
[31]
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TABLE 3. Comprehensive overview of Campylobacter source
attribution studies published between 2010 and 2015
Country Study period Source attribution Reference
Canada 2005–2007 Chicken: 64.5%
Cattle: 25.8%
Water: 8.4%
Wild birds: 2.3%
[7]
Denmark 2007–2008 Domestic chicken: 54%/38%a
Imported chicken: 17%/14%a
Cattle: 17%/16%a
[50]
The
Netherlands
Combined periods
2000–2007 and
2010–2011
Chicken: 68%
Cattle: 24%
Environment: 6%
Sheep + pig: 2%
[19]
The
Netherlandsb
2002–2003 Chicken: 66.2%
Cattle: 20.7%
Environment: 10.1%
Sheep: 2.5%
Pigs: 0.3%
[22]
Scotland 2005–2006 Poultry: 46.3%
Ruminant: 31.0%
Wild bird: 1.9%
[36]
Scotlandc 2005–2006 Ruminants: 54%
Chicken: 40%
Pigs: 6%
[9]
Switzerland 2002–2012 Chicken: 70.9%
Cattle: 19.3%
Dogs: 8.6%
Pigs: 1.2%
[18]
aThe ﬁrst percentage indicates source attribution determined by the asymmetric
island model. The second percentage indicates source attribution by the Campylo-
bacter source attribution model developed by the authors.
bAnimal data supplemented with data from UK, Scotland, Switzerland, New Zea-
land, Curaçao, Finland and USA.
cOnly C. coli included.
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[27–30]. In line with the summer peak in human infections,
higher isolation rates of Campylobacter from chickens in sum-
mertime, compared with the winter season, have been
observed [14,31,32]. However, the human infection peak often
precedes the prevalence peak of chicken slaughter batches,
suggesting that both may have acquired Campylobacter from the
same source [11,32,33]. Furthermore, MLST typing has shown
that the same sequence types (ST45, ST230 and ST677) occur
during the summer peak in both human patients and chickens,
which raises the question of common environmental sources
for these types [34,35]. Although the reasons for Campylobacter
seasonality are not well understood, increase in potential res-
ervoirs, human behaviour and climate may all play a role in the
shedding and subsequent transmission of the bacteria.
Furthermore, variation in the risk of acquiring campylobacter-
iosis between rural and urban regions has been documented
[7,29,36,37]. These studies suggest that chicken may play a
more prominent role in the transmission of Campylobacter to
humans residing in urban regions, whereas ruminant-associated
genotypes have often been more commonly detected from
people living in rural areas [7,29,36,37].
Despite the recognition of poultry as a substantial source
and reservoir for Campylobacter more risk factors have been
described. A substantial proportion of human CampylobacterClinical Microbiology and Infection © 2015 The Authors. Published by Elsevier Ltd on behalf of
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associated isolates are often divergent compared with domes-
tically acquired Campylobacter isolates [28,38,39]. In a Swiss risk
analysis study, the highest risk for travel-related Campylobacter
infection was among persons aged 20–59 years [10]. In other
risk analysis studies, Swedish residents travelling to other EU
countries had a risk of acquiring campylobacteriosis of 15.9 per
100 000 journeys abroad [40] and Dutch residents travelling to
Asia, Africa, Latin America, the Caribbean and southern Europe
had a higher risk of acquiring campylobacteriosis when
compared with residents travelling to northern and eastern
Europe and Oceania [38].
Workers at poultry abattoirs are an interesting group in
which to study the effect of occupational exposure to poten-
tially contaminated poultry on Campylobacter infection.
Recently, two studies, one conducted in Sweden [41] and the
other conducted in the USA [42], showed divergent results on
campylobacteriosis in poultry abattoir workers. In the US-based
study, the great majority (83%) of the symptomatic workers
with laboratory-veriﬁed Campylobacter infection had been
working at the slaughterhouse for less than a month [42]. In the
Swedish prospective study, workers who became stool culture
positive for Campylobacter did not exhibit symptoms, although
more than half (57%) had been employed for less than a year
[41]. Both studies included a small number of workers and it
will be of great interest to have more studies conducted on the
role of occupational exposure to better understand protective
immunity in humans and virulence of poultry-associated
Campylobacter.Antimicrobial resistanceFluoroquinolones, such as ciproﬂoxacin, and macrolides, such
as erythromycin, have been the primary antimicrobials used for
the treatment of human Campylobacter infections. Resistance to
ﬂuoroquinolones requires only one point mutation in the gyrA
gene and resistance has increased rapidly among chicken and
human Campylobacter isolates since the early 1990s [43].
Studies have shown a clear positive association between the use
of ﬂuoroquinolones in poultry production and increased
resistance among chicken and human Campylobacter isolates
[43–45], whereas in countries not permitting the use of ﬂuo-
roquinolones in poultry production, such as Australia and the
Nordic European countries, few resistant Campylobacter iso-
lates are found from chickens and humans with domestically
acquired infections [44]. The USA banned the use of the ﬂuo-
roquinolone enroﬂoxacin in chickens in 2005. Despite this,
resistance to ciproﬂoxacin in C. jejuni from chicken slaughter
batches has remained stable at 22% between 2005 and 2013,European Society of Clinical Microbiology and Infectious Diseases, CMI, 22, 103–109
nses/by-nc-nd/4.0/)
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17% in 2005 to 11% in 2013. Moreover, ciproﬂoxacin resis-
tance in human C. jejuni isolates in 2013 remained at the same
level as in 2005 (22%) (http://www.fda.gov/downloads/
AnimalVeterinary/SafetyHealth/AntimicrobialResistance/
NationalAntimicrobialResistanceMonitoringSystem/
UCM453398.pdf, last accessed 23 September 2015). The rea-
sons for persistence of resistance are not well understood.
In the EU member states, in 2013, ciproﬂoxacin resistance
among human Campylobacter isolates ranged from 23% in
Denmark to 92% in Spain [45]. Resistance to ciproﬂoxacin can
also be related to foreign travel, especially to Asia; in 2013 it
was shown that 90% of the tested isolates originating from Asia
were resistant [45]. Ciproﬂoxacin resistance among isolates
from broilers at slaughter ranged from 0% in Finland to 90% in
Spain [45]. Tetracycline resistance showed similar trends as
ciproﬂoxacin in the EU member states, whereas resistance to
macrolides, currently considered the drugs of choice for
treatment of human Campylobacter infections, was low, which is
probably because of their limited use in poultry production
[45]. Multidrug resistance has been uncommon in Campylo-
bacter derived from both humans and poultry [45].Intervention measuresReduction of Campylobacter-positive chicken ﬂocks, thereby
decreasing prevalence and bacterial counts on meat, is the most
relevant strategy to reduce the number of human Campylo-
bacter infections. Because the farm is the preliminary site of
Campylobacter entry into the production, the major interven-
tion strategies should be targeted at farm level. First-line
intervention is to improve the biosecurity (hygiene barriers
and restricted access), which prevents Campylobacter transfer
from the outside environment into rearing houses. This re-
quires increased education of farmers and awareness of man-
agement and biosecurity procedures and how to improve
these. Other intervention measures deal with abandoning
thinning of ﬂocks during the rearing period, because this pro-
cedure increases the transfer of Campylobacter into the ﬂock
[11]. Also, ﬂy screens combined with other adequate bio-
security measures have been shown to decrease the number of
positive batches in Denmark [33].
The interventions at slaughter process are less efﬁcient;
decreasing Campylobacter counts on products by 1 log unit has
been estimated to decrease human risk by 50%–90% [11].
Proper hygiene during slaughter and proper washing and chilling
of carcasses decrease the numbers of Campylobacter on car-
casses [11]. The European Food Safety Authority BIOHAZ
Panel has estimated that a public health risk reduction ofClinical Microbiology and Infection © 2015 The Authors. Published by Elsevier Ltd on behalf
This is an open access arti50%–90% could be achieved if all batches complied with
microbiological criteria with a critical limit of <1000
and <500 CFU/g of neck and breast skin, respectively [11].
Furthermore, the frequency of contaminated carcass samples
varied among the different European countries and there was a
trend for higher quantitative loads of Campylobacter on car-
casses in countries with higher Campylobacter prevalence in
both slaughter batches and carcasses [11]. These results indi-
cate that the interventions needed to reduce human health risks
are not the same in different countries.
Chemical decontamination of carcasses with, for example,
chlorine, chlorine dioxide, tri-sodium phosphate and lactic acid,
may be used to decrease the number of Campylobacter on
carcasses, but none of these treatments are allowed in the EU
[11]. In addition, freezing chicken meat has been successful in
reducing Campylobacter counts [11]. At retail level, selling the
meat prepacked and marinated as ready-to-oven products may
also decrease the consumer risk during food preparation at
home [46]. The ﬁnal consumer risks can be reduced by pre-
venting cross-contamination of ready-to-eat foods from cutting
boards, knives and hands during food preparation as well as
heating foods at temperatures that kill the organisms. However,
this requires increased consumer awareness; in a recent survey
by the Food Standards Agency in the UK, only 28% of the
people had heard of Campylobacter, compared with 90% who
had heard of Escherichia coli and Salmonella (http://www.food.
gov.uk/news-updates/news/2014/6084/fsw).
The list of potential measures to decrease poultry-associated
Campylobacter risk allows for selection and combination of the
best methods ﬁtting to local conditions. In New Zealand, a
country with a high incidence of campylobacteriosis, in-
terventions at different levels in the primary poultry production
have been effective in reducing the number of Campylobacter
infections [47]. In the EU, the BIOHAZ panel has presented a
detailed description of options on potential intervention pos-
sibilities and estimations of their effects on human Campylo-
bacter infections in different EU member states [11], but
implementation has not yet been very efﬁcient because of the
reluctance to make the necessary economic investments and
the general attitude towards the long-term management of
poultry production.ConclusionsHuman Campylobacter infections have been increasing in the
past decade and poultry has been identiﬁed as the major
contributor. It is evident that the majority of infections can be
attributed to poultry, yet these attributions differ between
countries and even for sparsely and highly populated areasof European Society of Clinical Microbiology and Infectious Diseases, CMI, 22, 103–109
cle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
108 Clinical Microbiology and Infection, Volume 22 Number 2, February 2016 CMIwithin a country. Peaks in human infections often precede
peaks in chicken, suggesting that other sources could supply
Campylobacter to both humans and chickens and that chickens
often act as a reservoir.
Colonization of poultry occurs at the farm level where it is
necessary to focus on enhancing the biosecurity and implement
monitoring. Intervention strategies and monitoring pro-
grammes in the primary poultry production chain have been
established, and shown to be successful in decreasing the
colonization rate of broilers in several northern European
countries and New Zealand.
Finally, in countries with a low colonization rate of chicken
ﬂocks, such as Finland, Norway and Sweden, sources other
than chickens may play a larger role, especially for domestically
acquired infections. Travel-associated infections are an impor-
tant factor to consider and together with the changing global
food markets, such as increasing consumption of imported
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